ALB and Cirrhosis: The “randomized-controlled trial comparing 20% ALbumin to Plasmalyte in patients with cirrhosis and Sepsis-induced hypotension” (ALPS) [70] compared 20% albumin to balanced crystalloid in cirrhotic patients with sepsis-induced hypotension.